Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Yongchun Song

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5100552323. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. Dosimetric comparison of multiple SBRT delivery platforms for pancreatic cancer. Co-author DOI 10.1186/s40001-024-02080-3↗
  2. Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy. Co-author DOI 10.7150/jca.87596↗
  3. Celiac Plexus Block After Stereotactic Body Radiotherapy Improves Pain Relief in Locally Advanced Pancreatic Cancer. Co-author DOI 10.2147/jpr.s247303↗
  4. Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancrea… Co-author DOI 10.2147/ott.s102784↗
  5. Analysis of clinical efficacy of CyberKnife(®) treatment for locally advanced pancreatic cancer. Co-author DOI 10.2147/ott.s81939↗
  6. High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose. Co-author DOI 10.3892/br.2013.211↗
  7. Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis. Co-author DOI 10.7150/ijms.5547↗
  8. [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression]. First author PMID 22445970↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Yuan · 3 shared papers, 2015–2023 · strength 0.35
  2. Yang Dong · 2 shared papers, 2015–2023 · strength 0.29
  3. Bo Jiang · 1 shared paper, 2024 · strength 0.23
  4. Chengxue Dang · 3 shared papers, 2012–2014 · strength 0.13
  5. Dongmei Diao · 3 shared papers, 2012–2014 · strength 0.13
  6. Ping Wang · 1 shared paper, 2020 · strength 0.11
  7. Kai Ji · 1 shared paper, 2020 · strength 0.11
  8. Weishuai Liu · 1 shared paper, 2020 · strength 0.11
  9. Yao Cheng · 2 shared papers, 2013–2014 · strength 0.09
  10. Ping Wang · 1 shared paper, 2016 · strength 0.05
  11. Maobin Meng · 1 shared paper, 2016 · strength 0.05
  12. Huaming Chen · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.